The use of short-acting bronchodilators in patients with chronic bronchoobstructive pathology at the present stage
Inhaled short-acting bronchodilators (beta-agonists and M-anticholinergics) have been used for a long time in patients with bronchoobstructive diseases, the main representatives of which are chronic obstructive pulmonary disease (COPD) and bronchial asthma (BA). Given the fact that most patients wit...
Main Authors: | K. A. Zykov, V. V. Vikentyev, I. V. Goloborodova, I. I. Kopchenov, O. V. Bondarec, T. F. Guseva, E. I. Sokolov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2021-09-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/6335 |
Similar Items
-
The value of bronchodilation test in the diagnosis and treatment of children with asthma
by: Yang Que, Huang Huarong
Published: (2022-10-01) -
Current views on the use of long-acting anticholinergic drug tiotropium in the treatment of bronchial asthma among children
by: E. V. Churyukina
Published: (2023-03-01) -
Experience of using double bronchodilation therapy in patients with COPD
by: I. V. Demko, et al.
Published: (2021-01-01) -
Pharmacotherapeutic strategy for COPD patients: focus on dual bronchodilators
by: A. I. Sinopalnikov
Published: (2021-10-01) -
Experience with the triple fixed combination in patients with chronic obstructive pulmonary disease
by: I. V. Demko, et al.
Published: (2022-01-01)